Judith Tsui, MD, MPH | Division of General Internal Medicine

Associate Professor

Medicine

Associate Director of the UW Addiction Medicine Fellowship

Faculty Information

Biography

Dr. Judith Tsui currently sees patients at the Adult Medicine Clinic at Harborview and at Evergreen Treatment Services. Dr. Tsui mentors medical students, physician fellows, and graduate students who are interested in clinical research on opioid use disorders and related co-morbidities.

Dr. Tsui welcomes emailed queries about research opportunities.

Education & Training:

Princeton University

Princeton, NJ

1991

New York University

New York, NY

1997

Residency

Oregon Health Sciences University

Portland, OR

1998–2000

MPH

Rollins School of Public Health, Emory University

Atlanta, GA

2004

Fellow

University of California

San Francisco, CA

2004–2008

Honors:

Magna Cum Laude, Princeton University

1991

Stanley Foundation Research Award, NYU School of Medicine

1994

Internal Medicine Wards Attending Teaching Award, Emory University School of Medicine

2002

Bay Area Clinical Research Symposium Finalist for Best Abstract

2006

Bay Area Clinical Research Symposium Finalist for Best Poster

2007

Research paper selected for NIDA “Director’s Report” by Dr. Nora Volkow

2015

Research paper selected for NIDA “Director’s Report” by Dr. Nora Volkow

2016

Contact

Email:

tsuij@uw.edu

Research & Clinical Interests

Research Interests:

Opioid use disorder
HIV
HCV
People who inject drugs

Publications

My NCBI:

My NCBI Bibliography

Publications:

Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 2014;174(12):1974–81. PMCID: PMC4506774.
Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Mao J, Edwards RR, Samet JH. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Drug Alcohol Depend. 2015;153:286–92. PMCID: PMC4509826.
Carey K, Huang W, Linas BP, Tsui JI. Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office-based program for opioid use disorders. J Subst Abuse Treat. 2016 Jul;66:54–9. PMCID: PMC5097249.
Tsui JI, Williams EC, Green PK, Berry K, Su F Ioannou GN. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Drug Alcohol Depend. 2016 Dec 1;169:101–109. PMID: 27810652.
Tsui JI, Burt R, Thiede H, Glick SN. Utilization of buprenorphine and methadone among opioid users who inject drugs. Subst Abus. 2018 Jan 2;39(1):83–88. PMID: 28796591
Gnatienko, N, Wagman JA, Cheng MD, Bazzi A, Raj A, Blokhina E, Toussova O, Forman LS, Lioznov D, Bridden C, Sullivan M, Bryant K, Samet JH, Tsui JI. Serodiscordant Partnerships and Opportunities for Pre-exposure Prophylaxis Among Partners of Women and Men Living with HIV in St. Petersburg, Russia. PLoS One. 2018 Nov 16;13(11). PMID: 30444903 PMCID: PMC6239322.

Printer-friendly